Home Cart Sign in  
Chemical Structure| 2055602-83-8 Chemical Structure| 2055602-83-8

Structure of BAY-1797
CAS No.: 2055602-83-8

Chemical Structure| 2055602-83-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY-1797 is a highly efficient, orally active selective P2X4 antagonist, with an IC50 of 211 nM for human P2X4. BAY-1797 exhibits little to no activity on other P2X ion channels, demonstrating anti-nociceptive and anti-inflammatory effects.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAY-1797

CAS No. :2055602-83-8
Formula : C20H17ClN2O4S
M.W : 416.88
SMILES Code : O=C(NC1=CC=C(OC2=CC=CC(Cl)=C2)C(S(=O)(N)=O)=C1)CC3=CC=CC=C3
MDL No. :MFCD32689580
InChI Key :CSJYMAFXYMYNCK-UHFFFAOYSA-N
Pubchem ID :124125214

Safety of BAY-1797

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Description
BAY-1797 is a potent, orally bioavailable, and selective antagonist of P2X4, exhibiting an IC50 of 211 nM against human P2X4. It has little to no activity on other P2X ion channels. BAY-1797 demonstrates anti-nociceptive and anti-inflammatory properties[1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.40mL

0.48mL

0.24mL

11.99mL

2.40mL

1.20mL

23.99mL

4.80mL

2.40mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories